FFTY vs. BIS
FFTY (Innovator IBD 50 ETF) and BIS (ProShares UltraShort Nasdaq Biotechnology) are both exchange-traded funds - FFTY is a Large Cap Growth Equities fund tracking the IBD 50 Index, while BIS is a Leveraged Equities fund tracking the NASDAQ Biotechnology Index (-200%). Both are passively managed. Over the past 10 years, FFTY returned 6.37%/yr vs -25.49%/yr for BIS. At a correlation of -0.59, they often move in opposite directions. FFTY charges 0.80%/yr vs 0.95%/yr for BIS.
Performance
FFTY vs. BIS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, FFTY achieves a 12.47% return, which is significantly higher than BIS's -27.05% return. Over the past 10 years, FFTY has outperformed BIS with an annualized return of 6.37%, while BIS has yielded a comparatively lower -25.49% annualized return.
FFTY
- 1D
- -2.66%
- 1M
- -5.30%
- 6M
- 4.82%
- YTD
- 12.47%
- 1Y
- 26.14%
- 3Y*
- 16.10%
- 5Y*
- -0.62%
- 10Y*
- 6.37%
BIS
- 1D
- 3.00%
- 1M
- -18.23%
- 6M
- -24.96%
- YTD
- -27.05%
- 1Y
- -56.42%
- 3Y*
- -28.45%
- 5Y*
- -17.36%
- 10Y*
- -25.49%
FFTY vs. BIS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
FFTY Innovator IBD 50 ETF | 12.47% | 23.38% | 18.36% | 12.40% | -51.08% | 11.92% | 18.20% | 25.74% | -16.76% | 37.62% |
BIS ProShares UltraShort Nasdaq Biotechnology | -27.05% | -45.95% | 4.79% | -6.54% | -2.14% | -14.74% | -56.01% | -41.01% | 5.14% | -36.98% |
Correlation
The correlation between FFTY and BIS is -0.41, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | -0.41 |
Correlation (3Y) Calculated over the trailing 3-year period | -0.47 |
Correlation (5Y) Calculated over the trailing 5-year period | -0.53 |
Correlation (10Y) Calculated over the trailing 10-year period | -0.58 |
Correlation (All Time) Calculated using the full available price history since Apr 9, 2015 | -0.59 |
The correlation between FFTY and BIS shifts across timeframes, from -0.59 (all time) to -0.41 (1 year), reflecting how their relationship changes across market environments.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
FFTY vs. BIS — Risk / Return Rank
FFTY
BIS
FFTY vs. BIS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Innovator IBD 50 ETF (FFTY) and ProShares UltraShort Nasdaq Biotechnology (BIS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| FFTY | BIS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.10 | ||
| Sortino ratioReturn per unit of downside risk | +3.46 | ||
| Omega ratioGain probability vs. loss probability | 1.15 | 0.75 | +0.40 |
| Calmar ratioReturn relative to maximum drawdown | 1.13 | -0.93 | +2.06 |
| Martin ratioReturn relative to average drawdown | 2.93 | -1.45 | +4.38 |
Loading charts...
Drawdowns
FFTY vs. BIS - Drawdown Comparison
The maximum FFTY drawdown since its inception was -59.46%, smaller than the maximum BIS drawdown of -99.89%. Use the drawdown chart below to compare losses from any high point for FFTY and BIS.
Loading charts...
Drawdown Indicators
| FFTY | BIS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -59.46% | -99.89% | +40.43% |
Max Drawdown (1Y)Largest decline over 1 year | -23.29% | -60.93% | +37.64% |
Max Drawdown (3Y)Largest decline over 3 years | -29.60% | -73.96% | +44.36% |
Max Drawdown (5Y)Largest decline over 5 years | -59.46% | -80.19% | +20.73% |
Max Drawdown (10Y)Largest decline over 10 years | -59.46% | -95.82% | +36.36% |
Current DrawdownCurrent decline from peak | -20.73% | -99.88% | +79.15% |
Average DrawdownAverage peak-to-trough decline | -22.31% | -90.07% | +67.76% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 8.94% | 38.97% | -30.03% |
Volatility
FFTY vs. BIS - Volatility Comparison
Innovator IBD 50 ETF (FFTY) has a higher volatility of 13.14% compared to ProShares UltraShort Nasdaq Biotechnology (BIS) at 12.50%. This indicates that FFTY's price experiences larger fluctuations and is considered to be riskier than BIS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| FFTY | BIS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.14% | 12.50% | +0.64% |
Volatility (6M)Calculated over the trailing 6-month period | 29.14% | 32.06% | -2.92% |
Volatility (1Y)Calculated over the trailing 1-year period | 36.51% | 41.05% | -4.54% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 29.81% | 43.99% | -14.18% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.76% | 46.20% | -18.44% |
FFTY vs. BIS - Expense Ratio Comparison
FFTY has a 0.80% expense ratio, which is lower than BIS's 0.95% expense ratio.
Dividends
FFTY vs. BIS - Dividend Comparison
FFTY's dividend yield for the trailing twelve months is around 1.20%, less than BIS's 5.78% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
BIS ProShares UltraShort Nasdaq Biotechnology | 5.78% | 5.25% | 3.73% | 1.75% | 0.00% | 0.00% | 0.45% | 2.11% | 0.37% | 0.00% |
FFTY Innovator IBD 50 ETF | 1.20% | 1.35% | 0.91% | 0.65% | 2.75% | 0.22% | 0.00% | 0.00% | 0.00% | 0.17% |
Frequently Asked Questions
FFTY and BIS have a correlation of -0.41, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
FFTY has higher volatility (13.14%) compared to BIS (12.50%). In terms of maximum drawdown, FFTY dropped -59.46% vs BIS's -99.89%.
On 10-year performance, FFTY leads with 6.37% vs -25.49% for BIS. On fees, FFTY is cheaper at 0.80% per year. On volatility, BIS has been the lower-risk option at 12.50%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, FFTY has performed better with a 6.37% return vs -25.49%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FFTY is cheaper with a 0.80% expense ratio, compared with 0.95% for BIS.
BIS has the higher dividend yield at 5.78%, compared with 1.20% for FFTY.
FFTY is categorized as Large Cap Growth Equities, while BIS is Leveraged Equities. FFTY tracks IBD 50 Index, while BIS tracks NASDAQ Biotechnology Index (-200%). They also come from different issuers: Innovator and ProShares. Their fees differ too: 0.80% for FFTY and 0.95% for BIS.
FFTY currently has the higher Sharpe Ratio (0.72 vs -1.38), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for FFTY and BIS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer